Figure 1
Microscopic image showing the polypoid formation of the fibroconnective branched axis with smooth muscle bands and covered by intestinal mucosa with a villous surface consistent with hamartomatous polyp. making it necessary for the patient to undergo surgery again one month later. Through various enterotomies, 10 hamartomatous polyps were resected, some of which were in an invaginated segment.
With these clinical and histopathologic data, PeutzJeghers syndrome (PJS) was diagnosed. A genetic study was requested in which complete sequencing of the STKB11 (LKB1) gene was carried out, confirming that the patient was a carrier of a pathogenic mutation in exon 4 (p.Asp194Asn). The patient has remained asymptomatic after surgery and has had no relevant findings in the surveillance tests. PJS is a rare genetic disease with dominant autosomal heredity caused by a germ cell mutation in the STK11 (LKB1) gene located on the 19p13.3 chromosome. It has an estimated incidence of one out of every 50,000-200,000 births. 1 Precisely because of the low frequency of this syndrome, there are no well established protocols in relation to surveillance and management.
PJS diagnosis is based on the presence of some of these criteria: 
Figure 3
On the left, the sagittal CT image shows various polypoid formations that are acting as the head of the intussusception of a jejunal segment (asterisk). On the right, the axial magnetic resonance enterographic image identifies several polypoid lesions in the jejunum and proximal ileum (yellow arrows).
---If there is no family history of PJS:
• Two or more hamartomatous polyps histologically confirmed, or • Any number of hamartomatous polyps with the characteristic mucocutaneous pigmentation ---If there is a family history of PJS, any number of hamartomatous polyps or mucocutaneous pigmentation
The cutaneous lesions appear in 95% of the patients and consist of dark brown-black pigmented macules that are most frequently located in the perioral region (94%), on the hands (74%), and in the buccal mucosa (66%). 3 The large majority of patients will present with hamartomatous polyps. They tend to be more frequently located in the small bowel (60-90%), followed by the colon (50-64%), stomach (49%), and rectum (32%), and can also be extraintestinal. Number and size is quite variable and they have no specific endoscopic characteristics. 4 To make the adequate differential diagnosis from the other types of polyposis, we must be familiar with the 3 types of polyps that are each associated with a specific syndrome. Among the adenomas, classic or attenuated familiar adenomatous polyposis or polyposis associated with the MYH gene are the most frequent syndromes. Serrated polyposis is associated with serrated polyps. And finally, in addition to PJS, juvenile polyposis, Cowden syndrome, and Bannayan-Riley-Ruvalcaba syndrome are among the types of hamartomatous polyposis, each with different clinical and extraintestinal manifestations. 5 The most frequent clinical onset of PJS is bowel obstruction (43%), followed by abdominal pain of ischemic origin (23%), rectorrhagia (14%), or polyp extrusion through the rectum (7%).
1 Up to 69% of the patients can present with some intussusception phenomenon produced by polyps > 15 mm, and thus the resection of polyps of those sizes could avoid such events. 6 There is also an increased risk in these patients for tumors. The most frequent neoplasias are those of the colon, followed by breast and small intestine tumors. The accumulative risk increases with age and varies from 37 to 93% with a relative risk of 9.9-18. 7 Surveillance of these patients should be directed at the risk for intussusception and neoplasias, but no screening protocols have been validated in clinical trials. There is a guide establishing some recommendations that include not only the endoscopic surveillance of gastrointestinal polyps, but also screening for extraintestinal neoplasias such as breast or testicular cancers. 8 The international group for the screening of cancer of the pancreas has recently included patients with PJS among the high risk patients, regardless of whether they have a family history of pancreatic cancer. 9 There is no consensus on how to treat polyps when they are detected, but even though the detection of dysplasia in hamartomas is low, endoscopic polypectomy is safe, given that emergency surgery is avoided and it protects the patient from developing intestinal and extraintestinal neoplasias.
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